You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Orphenadrine citrate - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for orphenadrine citrate and what is the scope of freedom to operate?

Orphenadrine citrate is the generic ingredient in two branded drugs marketed by Pai Holdings Pharm, Hikma, Rising, Sagent Pharms, Watson Labs, Bausch, Ascot, Bayshore Pharms Llc, Lupin, Sandoz, and Stevens J, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for orphenadrine citrate. Twenty suppliers are listed for this compound.

Summary for orphenadrine citrate
Drug Prices for orphenadrine citrate

See drug prices for orphenadrine citrate

Pharmacology for orphenadrine citrate

US Patents and Regulatory Information for orphenadrine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lupin ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040284-001 Jun 19, 1998 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bayshore Pharms Llc ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 091158-001 Jul 27, 2012 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 087062-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ascot ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 088067-001 Apr 6, 1983 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hikma ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 040463-001 Mar 4, 2003 AP RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Rising ORPHENADRINE CITRATE orphenadrine citrate INJECTABLE;INJECTION 040484-001 May 24, 2006 AP RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.